These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25195582)

  • 1. Advancing cancer patient care by integrating circulating tumor cell technology to understand the spatial and temporal dynamics of cancer.
    Rodriguez-Lee M; Kuhn P; Webb DR
    Drug Dev Res; 2014 Sep; 75(6):384-92. PubMed ID: 25195582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of circulating tumor cells-from bench to bedside.
    Li Y; Wu S; Bai F
    Semin Cell Dev Biol; 2018 Mar; 75():88-97. PubMed ID: 28899718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of current standpoints in profiling of circulating tumor cells.
    Kim K; Lee KH; Lee J; Choi J
    Arch Pharm Res; 2014 Jan; 37(1):88-95. PubMed ID: 24214218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating tumor cells as promising novel biomarkers in solid cancers.
    Lianidou ES; Strati A; Markou A
    Crit Rev Clin Lab Sci; 2014 Jun; 51(3):160-71. PubMed ID: 24641350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards a personalized breast cancer treatment approach guided by circulating tumor cell (CTC) characteristics.
    Onstenk W; Gratama JW; Foekens JA; Sleijfer S
    Cancer Treat Rev; 2013 Nov; 39(7):691-700. PubMed ID: 23683721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating tumor cells: detection, molecular profiling and future prospects.
    Jacob K; Sollier C; Jabado N
    Expert Rev Proteomics; 2007 Dec; 4(6):741-56. PubMed ID: 18067413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controversies in circulating tumor cell count during therapy.
    Raimondi C; Gradilone A; Gazzaniga P
    Expert Rev Mol Diagn; 2013 Jun; 13(5):499-507. PubMed ID: 23782256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of rare circulating tumor cells in cancer patients: technical aspects and clinical implications.
    Danova M; Torchio M; Mazzini G
    Expert Rev Mol Diagn; 2011 Jun; 11(5):473-85. PubMed ID: 21707456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New frontiers in circulating tumor cell analysis: A reference guide for biomolecular profiling toward translational clinical use.
    Becker TM; Caixeiro NJ; Lim SH; Tognela A; Kienzle N; Scott KF; Spring KJ; de Souza P
    Int J Cancer; 2014 Jun; 134(11):2523-33. PubMed ID: 24122526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organ-specific markers in circulating tumor cell screening: an early indicator of metastasis-capable malignancy.
    Paterlini-Bréchot P
    Future Oncol; 2011 Jul; 7(7):849-71. PubMed ID: 21732757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating tumor cells (CTC) detection: clinical impact and future directions.
    Paterlini-Brechot P; Benali NL
    Cancer Lett; 2007 Aug; 253(2):180-204. PubMed ID: 17314005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell analysis of CTCs with diagnostic precision: opportunities and challenges for personalized medicine.
    Alberter B; Klein CA; Polzer B
    Expert Rev Mol Diagn; 2016; 16(1):25-38. PubMed ID: 26567956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid translation of circulating tumor cell biomarkers into clinical practice: technology development, clinical needs and regulatory requirements.
    King JD; Casavant BP; Lang JM
    Lab Chip; 2014 Jan; 14(1):24-31. PubMed ID: 24190548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving pancreatic cancer diagnosis using circulating tumor cells: prospects for staging and single-cell analysis.
    Court CM; Ankeny JS; Hou S; Tseng HR; Tomlinson JS
    Expert Rev Mol Diagn; 2015; 15(11):1491-504. PubMed ID: 26390158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor heterogeneity and circulating tumor cells.
    Zhang C; Guan Y; Sun Y; Ai D; Guo Q
    Cancer Lett; 2016 May; 374(2):216-23. PubMed ID: 26902424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Looking back, to the future of circulating tumor cells.
    Friedlander TW; Premasekharan G; Paris PL
    Pharmacol Ther; 2014 Jun; 142(3):271-80. PubMed ID: 24362084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid functionalized surface highlights 5-methylcytosine-genomic content within circulating tumor cells.
    Malara N; Coluccio ML; Limongi T; Asande M; Trunzo V; Cojoc G; Raso C; Candeloro P; Perozziello G; Raimondo R; De Vitis S; Roveda L; Renne M; Prati U; Mollace V; Di Fabrizio E
    Small; 2014 Nov; 10(21):4324-31. PubMed ID: 25044603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current challenges in metastasis: disseminated and circulating tumor cells detection.
    Shahneh FZ
    Hum Antibodies; 2013; 22(3-4):77-85. PubMed ID: 24961866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sample Preparation Methods Following CellSearch Approach Compatible of Single-Cell Whole-Genome Amplification: An Overview.
    Swennenhuis JF; Terstappen L
    Methods Mol Biol; 2015; 1347():57-67. PubMed ID: 26374309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating tumor cells as a predictive biomarker in patients with hormone-sensitive prostate cancer.
    Goodman OB; Symanowski JT; Loudyi A; Fink LM; Ward DC; Vogelzang NJ
    Clin Genitourin Cancer; 2011 Sep; 9(1):31-8. PubMed ID: 21705286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.